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1.1 Role	  of	  Trypsin	  in	  the	  Body	  
 
	   Trypsin,	  a	  serine	  protease,	  is	  produced	  in	  the	  pancreas	  as	  the	  zymogen	  trypsinogen,	  and	  
stored	  in	  its	  inactive	  form	  so	  as	  not	  to	  kill	  pancreatic	  cells	  by	  cleaving	  cytoplasmic	  proteins	  
(Horton	  and	  others	  2006).	  After	  a	  meal,	  the	  pancreas	  is	  stimulated	  by	  cholecystokinin	  and	  the	  
zymogen	  is	  sent	  to	  the	  small	  intestine	  where	  it	  is	  activated	  by	  specific	  proteolysis	  by	  the	  
enzyme	  enteropeptidase,	  cleaving	  the	  lysine-­‐6	  –	  isoleucine-­‐7	  bond	  in	  the	  protease.	  Once	  this	  
takes	  place,	  the	  trypsin	  is	  free	  to	  activate	  other	  serine	  proteases,	  including	  chymotrypsin,	  
elastase,	  and	  more	  trypsin	  (by	  autocatalysis)(Horton	  and	  others	  2006).	  Once	  this	  step	  is	  
completed,	  trypsin	  cleaves	  peptide	  bonds	  containing	  carbonyl	  groups	  from	  arginine	  and	  lysine	  
(Horton	  and	  others	  2006).	  	  
1.2 Action	  of	  Soy	  Trypsin	  Inhibitors	  
 
Two	  types	  of	  protease	  inhibitors	  are	  found	  in	  soy:	  the	  Kunitz	  trypsin	  inhibitor	  (KTI)	  and	  
the	  Bowman-­‐Birk	  inhibitor	  (BBI).	  KTI	  is	  a	  strong	  inhibitor	  of	  trypsin,	  and	  is	  significantly	  larger	  
than	  BBI	  at	  20,100	  daltons.	  BBI	  inhibits	  both	  trypsin	  and	  chymotrypsin	  and	  is	  roughly	  8,000	  
daltons	  (DiPietro	  and	  Liener	  1989).	  When	  inhibitors	  are	  in	  the	  presence	  of	  trypsin,	  the	  active	  
site	  of	  the	  enzyme	  is	  blocked,	  an	  irreversible	  compound	  is	  formed	  instantly,	  and	  trypsin	  is	  
rendered	  ineffective	  (Blow	  and	  others	  1974;	  Kunitz	  1947).	  If	  ingested	  proteins	  are	  unable	  to	  be	  
hydrolyzed	  and	  broken	  down	  into	  smaller	  pieces	  by	  trypsin	  (and	  the	  other	  proteases	  it	  can	  
activate)	  due	  to	  trypsin	  inhibitors,	  it	  can	  result	  in	  gastric	  distress	  and	  lead	  to	  pancreatic	  
hypertrophy	  or	  hyperplasia	  (Horton	  and	  others	  2006;	  Smith	  and	  others	  1989).	  In	  rodent	  
models,	  animals	  fed	  either	  soy	  protein	  concentrate	  or	  direct	  concentrate	  of	  trypsin	  inhibitor	  
showed	  a	  dose-­‐related	  increase	  in	  pancreas	  weight	  due	  to	  both	  hyperplasia	  and	  hypertrophy	  
(Smith	  and	  others	  1989).	  This	  conclusion	  indicates	  that	  long-­‐term	  consumption	  of	  a	  diet	  high	  in	  
soy	  products	  with	  strong	  trypsin	  inhibitor	  activity	  may	  produce	  the	  same	  undesirable	  effects	  in	  
humans,	  as	  well.	  	  
1.3 Value	  of	  Soy	  and	  Quantification	  of	  Trypsin	  Inhibitors	  in	  Soy	  Ingredients	  
 
Food	  scientists	  at	  The	  Ohio	  State	  University	  have	  explored	  the	  incorporation	  of	  soy	  flour	  
and	  soy	  milk	  powder	  in	  baked	  products	  to	  confer	  certain	  health	  benefits.	  Specifically,	  soy	  bread	  
and	  soy-­‐almond	  bread	  have	  been	  used	  as	  an	  adjuvant	  therapy	  to	  men	  with	  prostate	  cancer.	  
However,	  trypsin	  inhibitors	  may	  diminish	  the	  value	  of	  soy	  in	  these	  novel	  food	  systems.	  Smith	  
and	  others	  (1989)	  discovered	  that	  the	  amount	  of	  soy	  inhibitors	  is	  directly	  related	  to	  the	  level	  of	  
inhibition	  seen	  in	  the	  body.	  Therefore,	  a	  product	  with	  two	  sources	  of	  soy	  such	  as	  the	  bread	  
developed	  at	  OSU	  is	  suspect	  to	  produce	  inhibition	  of	  trypsin	  in	  the	  body.	  Yet,	  there	  is	  a	  
modicum	  of	  research	  that	  outlines	  the	  levels	  of	  trypsin	  inhibitors	  in	  common	  soy	  products.	  
Trypsin	  inhibitors	  can	  be	  inactivated	  by	  heat,	  and	  since	  soy	  is	  typically	  processed	  to	  enhance	  its	  
nutritional	  value,	  some	  dismiss	  the	  inhibitors	  as	  an	  issue	  (Liener	  1986;	  Venter	  1999).	  However,	  
the	  heat	  sufficient	  to	  destroy	  trypsin	  inhibitors	  may	  be	  too	  high	  to	  preserve	  the	  nutritional	  
quality	  of	  soy.	  Thus,	  a	  balance	  must	  be	  in	  place	  during	  processing.	  Based	  on	  this,	  it	  is	  estimated	  
that	  5-­‐20%	  of	  trypsin	  inhibitors	  from	  the	  original	  soybeans	  remain	  active	  in	  commercially	  
available	  soy	  products	  (Liener	  1986).	  	  
Given	  that	  soy	  flour	  and	  soy	  milk	  powder	  are	  heat	  treated,	  it	  can	  be	  speculated	  that	  a	  
significant	  proportion	  of	  the	  original	  level	  of	  inhibitors	  is	  decreased	  in	  the	  processing	  of	  these	  
ingredients.	  Moreover,	  since	  both	  products	  are	  baked,	  it	  can	  be	  expected	  to	  see	  an	  additional	  
decrease	  in	  trypsin	  inhibitor	  levels.	  Therefore,	  the	  objective	  of	  this	  research	  was	  to	  determine	  if	  
soy	  bread	  contains	  active	  trypsin	  inhibitors	  after	  the	  baking	  process.	  Further,	  if	  the	  bread	  
exhibits	  trypsin	  inhibitor	  activity,	  to	  identify	  the	  ingredients	  that	  yield	  trypsin	  inhibition	  in	  soy	  
bread,	  and	  to	  quantify	  the	  levels	  of	  inhibition	  in	  each.	  	  
2-­‐Materials	  and	  Methods	  
 
The	  following	  procedure	  is	  based	  on	  AACC	  method	  22-­‐40	  (2010).	  	  
2.1	  Protein	  extraction	  of	  soy	  ingredients	  
 
	   The	  soy	  products	  evaluated	  in	  this	  research	  were	  soy	  flour	  (Baker’s	  soy,	  ADM	  Protein	  
Specialties	  Division;	  Decatur,	  IL),	  soy	  milk	  powder	  (Devansoy;	  Carroll,	  IA),	  and	  soy	  bread	  
(developed	  at	  OSU).	  The	  bread	  was	  ground	  in	  a	  blender	  (KitchenAid)	  to	  at	  least	  100	  mesh,	  
without	  the	  generation	  of	  heat.	  	  Each	  product	  was	  extracted	  in	  a	  ratio	  of	  1	  g	  ingredient	  to	  50	  
mL	  0.01	  NaOH	  for	  three	  hours,	  with	  a	  magnetic	  stirrer	  on	  low	  setting.	  	  
2.2	  Determination	  of	  Trypsin	  Inhibitor	  Activity	  
 
Reagents:	  
1.	  Tris	  buffer:	  6.05	  g	  tris	  (hydroxymethylamino)	  methane	  and	  2.94	  g	  CaCl2H20	  in	  900	  mL	  water.	  
Adjust	  pH	  to	  8.2,	  dilute	  volume	  to	  1	  L	  with	  water.	  	  
2.	  Substrate	  solution:	  40	  mg	  benzoyl-­‐DL-­‐arginine-­‐p-­‐nitroanilide	  hydrochloride	  (BAPA)	  (Sigma	  
Aldrich)	  in	  100	  mL	  Tris	  buffer.	  
3.	  Trypsin	  solution:	  4	  mg	  trypsin	  (Sigma	  Aldrich)	  in	  200	  mL	  0.001M	  HCl.	  
4.	  Acetic	  acid	  solution:	  30	  mL	  glacial	  acetic	  acid	  in	  70	  mL	  water.	  
	   	  
Portions	  of	  the	  extract	  were	  pipeted	  into	  duplicate	  test	  tubes	  (0,	  0.6,	  1.0,	  1.4,	  and	  1.8	  
mL)	  and	  adjusted	  to	  2.0	  mL	  with	  water.	  Each	  test	  tube	  received	  2.0	  mL	  of	  trypsin	  solution	  and	  
was	  agitated	  and	  heated	  in	  a	  water	  bath	  to	  37	  °C.	  Into	  each	  tube,	  5.0	  mL	  of	  BAPA	  solution	  
(previously	  heated	  to	  37	  °C)	  was	  added,	  and	  all	  tubes	  were	  replaced	  in	  the	  agitating	  water	  bath.	  
After	  exactly	  ten	  minutes,	  the	  reaction	  was	  stopped	  with	  1.0	  mL	  of	  acetic	  acid	  solution.	  Each	  
solution	  was	  filtered	  through	  Whatman	  number	  2	  syringes,	  and	  measured	  at	  410	  nm	  on	  a	  
spectrophotometer	  (Shimadzu).	  The	  blank	  was	  prepared	  by	  mixing	  2.0	  mL	  of	  sample	  extract	  
and	  5.0	  mL	  of	  BAPA,	  heating	  at	  37	  °C	  for	  ten	  minutes,	  adding	  1.0	  mL	  of	  acetic	  acid	  solution,	  
followed	  by	  the	  addition	  of	  2.0	  mL	  of	  the	  trypsin	  solution.	  Pure	  trypsin	  inhibitor	  (Sigma	  Aldrich)	  
was	  also	  tested	  in	  place	  of	  soy	  products	  as	  a	  control.	  	  
2.3	  Calculation	  of	  Trypsin	  Inhibitor	  Activity	  
	   	  
	   According	  to	  the	  AACC	  method,	  an	  increase	  of	  0.01	  in	  absorbance	  at	  410	  nm	  per	  10	  mL	  
of	  reaction	  mixture	  is	  equivalent	  to	  one	  trypsin	  unit	  (2010).	  Thus,	  one	  trypsin	  inhibitor	  unit,	  or	  
TIU,	  can	  be	  defined	  as	  a	  decrease	  in	  absorbance	  by	  0.01.	  The	  absorbances	  for	  each	  tube	  were	  
averaged	  and	  divided	  by	  0.01,	  then	  the	  differences	  between	  each	  tube	  were	  calculated	  
successively	  to	  acquire	  TIU/mL	  of	  suspension.	  TIU/mL	  of	  suspension	  was	  then	  plotted	  against	  
volume	  of	  extract	  and	  extrapolated	  to	  zero.	  If	  this	  graph	  is	  linear,	  then	  TIU/g	  can	  be	  calculated	  
by	  multiplying	  the	  extrapolated	  value	  by	  the	  dilution	  factor	  of	  the	  respective	  tube.	  If	  the	  graph	  
of	  TIU/mL	  of	  suspension	  versus	  volume	  of	  extract	  does	  not	  have	  a	  linear	  correlation,	  TIU/g	  
should	  be	  calculated	  using	  the	  average	  values	  for	  TIU/mL	  multiplied	  by	  the	  dilution	  factor.	  
2.4	  Optimization	  of	  Assay	  
2.4.1	  pH	  Monitoring	  
 
	   The	  pH	  of	  the	  suspension	  should	  be	  maintained	  between	  8.4	  and	  10.0	  to	  optimize	  the	  
action	  of	  trypsin	  on	  the	  substrate,	  BAPA.	  If	  not	  kept	  within	  this	  interval,	  the	  absorbances	  reflect	  
the	  low	  activity	  and	  typically	  are	  not	  in	  acceptable	  ranges	  for	  data	  collection.	  	  
2.4.2	  Concentration	  of	  enzyme	  and	  substrate	  
 
	   In	  order	  to	  achieve	  absorbances	  within	  an	  acceptable	  spectrophotometric	  range	  (0.1-­‐
1.0),	  the	  concentration	  of	  trypsin	  and	  BAPA	  can	  be	  tripled.	  The	  assay	  is	  most	  effective	  when	  the	  
concentrations	  of	  both	  solutions	  are	  increased,	  rather	  than	  just	  one.	  	  
2.4.3	  Elimination	  of	  Fat	  
 
	   Free	  fatty	  acids	  in	  soy	  products	  can	  act	  as	  strong	  inhibitors	  of	  trypsin,	  thus	  interfering	  
with	  the	  basic	  nature	  of	  this	  assay	  (Smith	  and	  others	  1980).	  Three	  different	  methods	  were	  used	  
to	  eliminate	  fat	  from	  the	  soy	  product	  before	  extraction.	  The	  first	  method	  mixed	  50	  mL	  of	  cold	  
hexane	  with	  the	  sample	  in	  a	  separatory	  funnel	  for	  one	  minute,	  and	  the	  fat	  layer	  was	  removed.	  
This	  process	  was	  completed	  three	  times	  for	  each	  sample.	  The	  second	  method	  was	  soxhlet	  
extraction,	  which	  started	  with	  5	  g	  of	  each	  soy	  product	  added	  to	  individual	  cellulose	  extraction	  
thimbles.	  Each	  thimble	  was	  placed	  inside	  the	  soxhlet	  extraction	  chamber,	  and	  round	  bottom	  
receiving	  flasks	  with	  125	  mL	  of	  petroleum	  ether	  and	  boiling	  beads	  in	  each	  were	  attached	  to	  the	  
bottom	  of	  the	  chambers.	  The	  heat	  was	  turned	  on	  to	  medium	  and	  the	  samples	  were	  refluxed	  for	  
twelve	  hours.	  After	  the	  extraction	  was	  complete,	  the	  soy	  products	  were	  removed	  for	  protein	  
extraction	  for	  the	  assay.	  Third,	  centrifugation	  of	  the	  samples	  was	  performed	  at	  10,000	  x	  g	  for	  
15	  minutes	  at	  4	  °C	  (Sorvall	  RC5C	  Plus	  with	  SM-­‐24	  Rotor;	  Thermo	  Scientific;	  Waltham,	  
Massachusetts).	  	  
3-­‐Results	  and	  Discussion	  
3.1	  Quantification	  of	  Trypsin	  Inhibitors	  
 
	   Figure	  3.1	  represents	  the	  relationship	  between	  trypsin	  activity	  with	  increase	  of	  soy	  
sample	  extract.	  If	  uninhibited,	  trypsin	  cleaves	  BAPA	  to	  product	  p-­‐nitroaniline,	  a	  yellow	  pigment	  
that	  absorbs	  at	  410	  nm.	  If	  trypsin	  is	  inhibited,	  the	  absorbance	  will	  be	  low.	  When	  pure	  trypsin	  
inhibitor	  was	  tested,	  as	  volume	  increased,	  the	  inhibitory	  action	  increased	  as	  well,	  and	  trypsin	  
was	  unable	  to	  cleave	  BAPA,	  indicated	  by	  the	  decrease	  in	  absorption.	  Soy	  bread	  shows	  the	  best	  
linear	  relationship	  between	  these	  two	  factors,	  suggesting	  that	  it	  contains	  trypsin	  inhibitors.	  
However,	  soy	  flour	  has	  an	  average	  absorbance	  of	  0.25.	  Therefore,	  the	  trypsin	  in	  the	  reaction	  
was	  able	  to	  act	  without	  interference,	  indicating	  that	  this	  soy	  ingredient	  contains	  no	  trypsin	  
inhibitors.	  	  
	  
Figure	  3.1.	  Absorbance	  at	  410	  nm	  as	  it	  relates	  to	  volume	  of	  extract	  and	  trypsin	  activity	  for	  pure	  




























	   	  
Figure	  3.2	  shows	  the	  actual	  values	  of	  trypsin	  inhibitor	  units	  per	  mL	  of	  suspension	  and	  
the	  relation	  to	  the	  volume	  of	  the	  extract,	  or	  amount	  of	  soy	  sample.	  In	  this	  graph,	  slope	  is	  
indicative	  of	  the	  amount	  of	  trypsin	  inhibitors	  contained	  within	  each	  sample,	  as	  the	  final	  
extrapolated	  value	  is	  that	  which	  gives	  the	  TIU/g	  of	  soy	  ingredient.	  Soy	  flour	  has	  a	  slope	  of	  zero,	  
which	  supports	  the	  evidence	  in	  Figure	  3.1	  that	  there	  are	  no	  trypsin	  inhibitors	  in	  this	  soy	  
ingredient.	  There	  is	  a	  strong,	  positive	  linear	  correlation	  between	  TIU/mL	  and	  volume	  of	  extract	  
for	  pure	  trypsin	  inhibitor,	  which	  is	  to	  be	  expected.	  For	  soy	  bread,	  there	  is	  also	  a	  positive	  linear	  
correlation,	  further	  indication	  that	  trypsin	  inhibitors	  are	  present.	  	  
	  
Figure	  3.2.	  Calculation	  of	  TIU/mL	  of	  suspension	  of	  pure	  trypsin	  inhibitor,	  soy	  flour,	  and	  soy	  
bread.	  	  
	  
	   The	  results	  from	  final	  calculations	  of	  TIU/g	  of	  soy	  product	  are	  shown	  in	  Table	  3.1.	  As	  
expected,	  the	  soy	  flour	  has	  no	  trypsin	  inhibitor	  units	  per	  gram	  of	  flour.	  This	  indicates	  that	  the	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bread,	  however,	  contains	  2.89	  TIU/g	  of	  bread.	  This	  was	  not	  expected,	  as	  it	  was	  hypothesized	  
that	  the	  baking	  process	  would	  inactivate	  any	  residual	  trypsin	  inhibitors	  the	  in	  the	  soy	  
ingredients	  and	  result	  in	  no	  inhibitory	  activity.	  Throughout	  the	  testing,	  soy	  milk	  presented	  a	  
number	  of	  issues	  with	  the	  assay,	  which	  led	  to	  the	  extensive	  optimization	  outlined	  above.	  Since	  
inconclusive	  results	  were	  found	  for	  this	  soy	  ingredient,	  it	  can	  be	  hypothesized	  that	  soy	  milk	  
powder	  is	  the	  ingredient	  in	  soy	  bread	  that	  contributes	  trypsin	  inhibitors.	  	  
Table	  3.1.	  Trypsin	  inhibitor	  units	  per	  gram	  of	  soy	  flour	  and	  soy	  bread.	  	  
Sample	   TIU/g	  
Soy	  Flour	   0.00	  




	   From	  the	  results,	  it	  can	  be	  concluded	  that	  soy	  flour	  is	  a	  viable	  option	  for	  incorporation	  in	  
other	  soy-­‐based	  foods	  without	  the	  consequence	  of	  trypsin	  inhibition	  in	  the	  body.	  While	  soy	  
bread	  contains	  2.89	  TIU/g	  of	  bread,	  this	  should	  not	  be	  cause	  for	  alarm.	  This	  is	  a	  very	  low	  level	  of	  
trypsin	  inhibitors,	  and	  will	  not	  cause	  significant	  distress	  to	  the	  gastric	  system	  of	  the	  consumer.	  
Since	  soy	  flour	  exhibited	  no	  inhibitory	  activity,	  it	  can	  be	  inferred	  that	  soy	  milk	  powder	  is	  the	  
cause	  of	  trypsin	  inhibitors	  in	  the	  soy	  bread.	  However,	  optimization	  of	  the	  assay	  did	  not	  prove	  to	  
be	  entirely	  successful	  for	  this	  ingredient.	  Thus,	  further	  testing	  and	  optimization	  must	  be	  
performed	  to	  quantify	  the	  levels	  of	  trypsin	  inhibitors	  in	  this	  ingredient.	  Once	  definitive	  results	  
are	  determined,	  the	  reduction	  of	  trypsin	  inhibitors	  by	  baking	  can	  also	  be	  assessed.	  




AACC.	  2010.	  Approved	  methods	  of	  the	  AACC	  (11th	  ed.).	  St.	  Paul,	  MN:	  American	  Association	  of	  
Cereal	  Chemists.	  
Blow	  DM,	  Janin	  J,	  Sweet	  RM.	  1974.	  Mode	  of	  action	  of	  soybean	  trypsin	  inhibitor	  (Kunitz)	  as	  a	  
	   model	  for	  specific	  protein-­‐protein	  interactions.	  Nature.	  249(54).	  
DiPietro	  CM,	  Liener,	  IE.	  1989.	  Soybean	  Protease	  Inhibitors	  in	  Foods.	  J.	  Food	  Sci.	  54(3):	  606-­‐609,	  
617.	  
Horton	  HR,	  Moran,	  LA,	  Scrimgeour,	  KG,	  Perry,	  MD,	  Rawn	  JD.	  2006.	  Principles	  of	  Biochemistry.	  
4th	  ed.	  Upper	  Saddle	  River,	  NJ:	  Pearson	  Prentice	  Hall.	  852	  p.	  
Kunitz	  M.	  1947.	  Crystalline	  soybean	  trypsin	  inhibitor.	  J.	  Gen.	  Physiol.	  30(4):	  291-­‐310.	  
Liener,	  IE.	  1986.	  Trypsin	  Inhibitors:	  Concern	  for	  Human	  Nutrition	  or	  Not?	  J.	  Nutr.	  116:920-­‐923.	  
Smith	  C,	  Van	  Megen	  W,	  Twaalfhoven	  L,	  Hitchcock	  C.	  1980.	  The	  Determination	  of	  Trypsin	  
Inhibitor	  Levels	  in	  Foodstuffs.	  J.	  Sci.	  Food	  Agric.	  31(4):341-­‐350.	  	  
Smith	  JC,	  Wilson	  FD,	  Allen	  PV,	  Berry	  DL.	  1989.	  Hypertrophy	  and	  hyperplasia	  of	  the	  rat	  
	   pancreas	  produced	  by	  short-­‐term	  dietary	  administration	  of	  soya-­‐derived	  protein	  and	  
	   soybean	  trypsin	  inhibitor.	  J.	  Appl.	  Toxic.	  9(3):175-­‐179.	  
Venter	  CS.	  1999.	  Health	  benefits	  of	  soy	  beans	  and	  soy	  products:	  a	  review.	  J.	  Fam.	  Eco.	  And	  
	   Cons.	  Sci.	  27(1):24-­‐33.	  
	  
